Immuron Limited is an Australia-based biopharmaceutical company focused on the research into the use of polyclonal antibodies for the treatment and prevention of diseases. During the fiscal year ended June 30, 2009, the Company operated in two segments: the conduct conduct of research and development activities and the manufacturing of colostrum hyper immune products, including Travelan. Anadis ESP Pty Ltd is the wholly owned subsidiary of the Company.